Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Short term Debt: 2018-2021

Historic Short term Debt for AC Immune (ACIU) over the last 3 years, with Dec 2021 value amounting to $21.7 million.

  • AC Immune's Short term Debt was N/A to $21.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $21.5 million, marking a year-over-year change of. This contributed to the annual value of $21.7 million for FY2021, which is N/A change from last year.
  • AC Immune's Short term Debt amounted to $21.7 million in FY2021, which was up 3,186.68% from $658,770 recorded in FY2019.
  • Over the past 5 years, AC Immune's Short term Debt peaked at $21.7 million during FY2021, and registered a low of $339.54 during FY2018.
  • Over the past 2 years, AC Immune's median Short term Debt value was $11.2 million (recorded in 2019), while the average stood at $11.2 million.
  • Data for AC Immune's Short term Debt shows a peak YoY soared of 193,918.22% (in 2019) over the last 5 years.
  • Over the past 3 years, AC Immune's Short term Debt (Yearly) stood at $339.54 in 2018, then spiked by 193,918.22% to $658,770 in 2019, then reached $21.7 million in 2021.